{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,9]],"date-time":"2025-11-09T07:26:40Z","timestamp":1762673200009,"version":"3.44.0"},"reference-count":21,"publisher":"MJS Publishing, Medical Journals Sweden AB","issue":"5","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Acta Oncologica"],"published-print":{"date-parts":[[2001,1]]},"DOI":"10.1080\/028418601750444150","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T11:29:22Z","timestamp":1027682962000},"page":"609-614","source":"Crossref","is-referenced-by-count":15,"title":["Issues of Normal Tissue Toxicity in Patient and Animal Studies - Effect of Carbogen Breathing in Rats after 5-Fluorouracil Treatment"],"prefix":"10.2340","volume":"40","author":[{"family":"John R. Griffiths, Dominick J.O. Mc","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1183","published-online":{"date-parts":[[2009,7,8]]},"reference":[{"key":"CIT0001","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00001813-199406000-00002","volume":"5","author":"Findlay MP","year":"1994","journal-title":"Anticancer Drugs"},{"key":"CIT0002","first-page":"101","author":"Peters GJ","year":"1999","journal-title":"Fluoropyrimidines as antifolate drugs"},{"key":"CIT0003","first-page":"380","volume":"11","author":"Wolf W","year":"1998","journal-title":"Non-invasive 19F-MRS of 5-fluorouracil in pharmacokinetics and pharmacodynamic studies. NMR Biomed"},{"key":"CIT0004","first-page":"2363","volume":"59","author":"Schlemmer HP","year":"1999","journal-title":"Cancer Res"},{"key":"CIT0005","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/BF00685670","volume":"31","author":"Peters GJ","year":"1993","journal-title":"Cancer Chemother Phar-macol"},{"key":"CIT0006","first-page":"1327","volume":"2","author":"van Laar JA","year":"1996","journal-title":"Clin Cancer Res"},{"key":"CIT0007","first-page":"42","volume":"7","author":"JaM RK","year":"1994","journal-title":"Sci Am"},{"issue":"1","key":"CIT0008","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/0167-8140(91)90190-R","volume":"20","author":"Rojas A","year":"1991","journal-title":"Radiother Oncol"},{"key":"CIT0009","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1038\/bjc.1997.10","volume":"75","author":"Rodrigues LM","year":"1997","journal-title":"Br J Cancer"},{"key":"CIT0010","first-page":"1185","volume":"58","author":"McSheehy PMJ, Robinson SP, Ojugo ASE, et al.","year":"1998","journal-title":"Cancer Res"},{"key":"CIT0011","first-page":"197","volume":"8","author":"Robinson SP","year":"1998","journal-title":"Magnetic resonance imaging technique for monitoring changes in tumor oxygenation and blood flow. Semin Radiat Oncol"},{"key":"CIT0012","first-page":"2461","volume":"35","author":"de Bruijn EA","year":"1986","journal-title":"Non-linear pharmacokinetics of 5-fluorouracil as described by in vivo behaviour of 5,6 dihydro-5-fluorouracil. BiochemPharmacol"},{"key":"CIT0013","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/0959-8049(94)00477-M","volume":"31","author":"van der Wilt CL","year":"1995","journal-title":"Eur J Cancer"},{"key":"CIT0014","first-page":"20","volume":"46","author":"Peters GJ","year":"1986","journal-title":"Sensitivity to human, murine and rat cells to 5-fluorouracil and 5'-deoxy-5-fluorouridine in relation to drug-metabolizing enzymes. Cancer Res"},{"key":"CIT0015","first-page":"4922","volume":"52","author":"van der Wilt CL","year":"1992","journal-title":"Cancer Res"},{"key":"CIT0016","first-page":"530","author":"Peters GJ","year":"1995","journal-title":"Antimetabolites"},{"key":"CIT0017","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/abio.1995.1515","volume":"231","author":"Peters GJ","year":"1995","journal-title":"Anal Biochem"},{"key":"CIT0018","first-page":"303","volume":"60","author":"McSheehy PMJ, Prior MJW,","year":"1989","journal-title":"Prediction of 5-fluorouracil cytotoxicity towards the Walker carcinosar-coma using peak integrals of fluoronucleotides measured by MRS in vivo. Br J Cancer"},{"key":"CIT0019","first-page":"1384","volume":"51","author":"Sijens PE","year":"1991","journal-title":"Cancer Res"},{"key":"CIT0020","first-page":"1795","volume":"94","author":"Pritchard DM","year":"1997","journal-title":"Inhibition of uridine but not thymidine of p53-de-pendent intestinal apoptosis initiated by 5-fluorouracil: evidence for the involvement of RNA perturbation. PNAS"},{"key":"CIT0021","first-page":"516","volume":"44","author":"Dzik-Jurasz ASK, Collins DJ, Leach MO, Rowland","year":"2000","journal-title":"Gall bladder localisation of 19F MRS catabolite signals in patients receiving bolus and protracted venous infusional 5-fluoruracil. Magn Reson Med"}],"container-title":["Acta Oncologica"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.1080\/028418601750444150","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T18:04:30Z","timestamp":1756404270000},"score":1,"resource":{"primary":{"URL":"https:\/\/medicaljournalssweden.se\/actaoncologica\/article\/view\/25982"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,1]]},"references-count":21,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2009,7,8]]},"published-print":{"date-parts":[[2001,1]]}},"alternative-id":["10.1080\/028418601750444150"],"URL":"https:\/\/doi.org\/10.1080\/028418601750444150","relation":{},"ISSN":["0284-186X","1651-226X"],"issn-type":[{"type":"print","value":"0284-186X"},{"type":"electronic","value":"1651-226X"}],"subject":[],"published":{"date-parts":[[2001,1]]}}}